BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
GENVEC (NQ: GNVC)
2.600 USD  -0.070 (-2.62%)
Streaming Delayed Price  /  Updated: 1:11 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(GNVC) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 23, 2014
(Stock Blog Hub, 12/30/10)
Even though the markets trimmed the intra-day rally during closing hours on Wednesday, the benchmarks still moved modestly upward to achieve new highs. After-effects of...(read more)
(Stock Wizard, 9/14/10)
Shares of Icagen, Inc. (NASDAQ: ICGN) slumped as much as 26% after it announced  that due to the occurrence of a serious adverse event in the photosensitivity study of ICA-105665, the Company...(read more)
(Stock Blog Hub, 3/31/10)
In a major setback, GenVec (GNVC) had to discontinue its final stage trial of TNFerade in patients with pancreatic cancer following an interim analysis. The interim...(read more)
GenVec (GNVC) Company Overview

There is no analysis for GNVC yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here